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ABSTRACT 
Oxidative stress is associated with diabetes me- 
llitus, a condition characterized by increased 
prevalence and progression rate of cardiovas-
cular disease. NFE2-related factor 2 (Nrf2) is a 
master regulator of cellular detoxification re-
sponses and redox status. The aim of this study 
was to examine associations between type 2 
Diabetes Mellitus (T2DM), oxidative stress and 
the expression of NFE2-related factor 2 (Nrf2) in 
a population of diabetic patients living in Juana 
Koslay City, San Luis, Argentina. In addition, we 
evaluated the functional relevance of Nrf2 by 
measuring the HO-1 expression among persons 
with type 2 diabetes. We measured clinical and 
biochemical parameters related to lipid metabo-
lism and oxidative stress in a population of Type 
2 Diabetes Mellitus patients (T2DM, n = 40) and 
controls (Co, n = 30). Compared to Co, T2DM 
patients had higher fasting serum glucose, gly- 
cated hemoglobin, triglycerides, total choles- 
terol, low-density lipoprotein cholesterol, and 
thiobarbituric acid reactive substances and 
lower high-density lipoprotein cholesterol. T2DM 
individuals had also higher atherogenic index 
and body mass index than controls. We also 
founded that HO-1 mRNA in whole blood was 
lower in T2DM than controls, suggesting that 
T2DM may have an altered antioxidant response 
to oxidative stress. Interestingly, we found re-
duced Nrf2 mRNA in whole blood from T2DM 
compared to Co. The results from this study 
provide novel evidence that genes associated to 
antioxidant defense mechanisms are markedly 
reduced in patients with type 2 diabetes, and 
that the reduction in the expression of these 
genes could be associated to hyperglycemia 
and increased levels of MDA. Linear regression 
analysis revealed that there was a strong and 
positive correlation between the changes of Nrf2 
and HO-1 expression levels. 
 
Keywords: Type 2 Diabetes Mellitus; HO-1;  
Nrf2 and TBAR’S 
1. INTRODUCTION 
The pathogenesis of Type 2 Diabetes Mellitus (T2DM) 
has not been fully elucidated; however, there is growing 
evidence linking this disease to oxidative stress [1-3]. 
Oxidative stress, resulting from increased production or 
decreased removal of reactive oxygen species (ROS), 
plays a key role in the pathogenesis of late diabetes 
complications [2] and insulin—stimulated glucose up- 
take [4]. 
Increasing evidence indicates that increased produc-
tion of reactive oxygen or nitrogen species (ROS or RNS) 
and/or impaired endogenously protective mechanism is 
the major factor responsible for the development and 
progression of vascular complications in diabetic patients, *Corresponding author. 
Copyright © 2013 SciRes.                                                                    OPEN ACCESS 
S. Siewert et al. / Journal of Diabetes Mellitus 3 (2013) 71-78 72 
although several other mechanisms were also proposed 
[5-7]. 
One of the most important antioxidant machineries is 
the Nrf2 system, with the transcription factor Nrf2 as the 
central component [8]. The transcriptional factor NFE2- 
related factor 2 (Nrf2), a member of the cap’n’collar 
family, is a master regulator of cellular detoxification 
responses and redox status [9]. Under physiological con-
ditions Nrf2 locates in the cytoplasm and binds to its 
inhibitor kelch-like ECH-associated protein 1 (KEAP1) 
[10]. KEAP1 could mediate a rapid ubiquitination and 
subsequent degradation of Nrf2 by the proteasome [10]. 
Upon exposure of cells to oxidative stress or electro-
philic compounds, Nrf2 is released from KEAP1 and 
translocates into the nucleus. There, it binds to antioxi- 
dant-responsive elements (ARE) in the genes encoding 
antioxidant enzymes such as NADPH quinoneoxido- 
reductase (NQO1), heme oxygenase-1 (HO-1), gluta- 
thione S transferase, superoxide dismutase (SOD), cata-
lase, and γ-glutamylcysteine synthetase, increasing their 
expression to play a role in the detoxification, antioxi-
dant, and anti-inflammatory processes [9-11].  
Among a panel of potential candidate genes related to 
oxidative stress, the heme oxygenase-1 (HO-1) gene has 
drawn much attention with its potent antiinflammatory, 
antioxidant, and antiproliferative effects [12]. Heme oxy- 
genase is a microsomal rate-limiting enzyme responsible 
for the oxidation and degradation of heme into biologi- 
cally active metabolites—biliverdin, which is rapidly 
reduced to bilirubin by biliverdin reductase, carbon mo- 
noxide, and iron [13]. Three mammalian heme oxygen- 
nase isoforms have been identified. Among them, the 
inducible isoform HO-1 is a stress-responsive protein 
ubiquitously distributed in mammalian tissues and can be 
induced by various oxidative agents [14,15]. The induc- 
tion of HO-1 has been considered an adaptive cellular 
defense response protecting cells or tissues against inju- 
ries in pathophysiological states, attributed to the anti- 
oxidant properties of bilirubin and biliverdin, the extru- 
sion and sequestration of cellular free iron by ferritin, 
and the antiapoptotic and anti-inflammatory effects of 
carbon monoxide [12,14-16]. The beneficial role of 
HO-1 in diabetes has been reported in animal models and 
in in vitro assays involving exposure to glucose [12,17], 
but little information on humans is available. 
Our aim in this study was to examine associations 
between type 2 Diabetes Mellitus (T2DM), oxidative 
stress and the expression of NFE2-related factor 2 (Nrf2) 
in a population of diabetic patients living in Juana 
Koslay City, San Luis, Argentina. In addition, we evalu- 
ated the functional relevance of Nrf2 by measuring the 
HO-1 expression among persons with type 2 diabetes. 
2. RESEARCH DESIGN AND METHODS 
2.1. Subjects 
The present study was carried out in accordance to the 
guidelines of the Helsinki Declaration. A total of 70 vo- 
lunteers (40 patients with type 2 diabetes and 30 healthy 
age-matched controls) participated in this investigation. 
Criteria published by the American Diabetes Association 
were used to diagnose T2DM [18]. These patients reside 
in Juana Koslay, San Luis, Argentina. The protocol for 
this study was approved by the local Institutional Review 
Board, and a written informed consent was obtained 
from each patient to be enrolled. During an initial inter- 
view with each patient, they were asked for diseases, 
medication and smoking histories. Exclusion criteria 
included liver, kidney and thyroid diseases, as well as the 
use of anti-lipemic drugs. 
2.2. Anthropometric and Clinical Data 
For each subject enrolled, height (meters) and weight 
(Kg) measurements were acquired. Height and weight 
were measured to the nearest 0.5 cm and 0.1 Kg, respec- 
tively. The body mass index (BMI) was calculated as 
weight divided by height squared (Kg/m2). Those pa- 
tients with a BMI equal or greater than 30.00 Kg/m2 
were considered as obese.  
2.3. Blood Sampling 
Blood samples were obtained from patients that had 
fasted overnight for a minimum of 12 h and were drawn 
from the antecubital vein between 08:00 am and 09:30 
am. Blood sample were obtained with or without antico- 
agulants to obtain plasma and serum, respectively. After 
separation of plasma, cell pellets were used to extract 
RNA (see below). 
2.4. Biochemical Measurement 
Fasting plasma glucose (FPG) was measured by using 
a glucose oxidase method with a commercial enzymatic 
kit (Wiener Lab, Rosario, Argentina) and Glycated he- 
moglobin (HbA1c) concentration was measured with a 
coupled ionic-exchange chromatography/spectrophoto- 
metric assay (BioSystems, Barcelona, Spain) in a Bayer 
Express Plus Chemistry Analyzer (Bayer Diagnostics, 
Siemens, Germany). Total cholesterol (TC), triglycerides 
(TG) and HDL-c concentrations were measured using 
commercial kits by following manufacturer’s instructions 
(Wiener Lab, Rosario, Argentina) in a Bayer Express 
Plus Chemistry Analyzer (Bayer Diagnostics, Siemens, 
Germany). Low density lipoprotein-cholesterol (LDL-c) 
was calculated with the Friedewald formula: LDL-c = 
total cholesterol (mg/dL) − HDL-c (mg/dL) – triglyc-
erides (mg/dL)/5 [19].  
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2.5. Lipid Peroxidation Assay 
Plasma lipid peroxidation was determined as described 
by Jentzsch et al. (1969). Plasma protein was precipi- 
tated in trichloroacetic acid (TCA). MDA produced dur- 
ing lipid peroxidation, reacts with thiobarbituric acid 
(TBA) and generas a pink-colored complex. After some 
further steps, the absorbance of the supernatant was 
measured spectrophotometrically at 532 nm (Bayer Di-
agnostics, Siemens, Germany) using 1,1,3,3-Tetra eth-
oxypropane (Sigma Chemical, St Louis, MO) as standard. 
TBARS concentration was determined in triplicate and 
all results are presented in M. 
2.6. Measurement of Gene Expression 
Total RNA was isolated from cell pellets using the 
TRIzol reagent following manufacturer’s instructions 
(Life Technologies, Carlsbad, CA). Agarose gel electro- 
phoresis and ethidium bromide staining confirmed the 
purity and integrity of isolated RNA. RNA concentration 
was assessed by spectrophotometric measurements at 
260/280 nm. Then, ten micrograms of total RNA were 
reverse-transcribed with 200 units of moloney-murine 
leukemia virus (MMLV) reverse transcriptase (Promega) 
using random hexamers as primers in 20 μL reaction 
mixture following the instructions provided by the 
manufacturer. The reverse transcription reactions were 
performed using a GeneAmp PCR system 2400 (Perkin- 
Elmer, Wellesley, MA) with conditions at 65˚C for 10 
min, 37˚C for 60 min, and 90˚C for 5 min. PCR was used 
to quantify human Nrf2, HO-1 and Cyclophiline A ex- 
pression. PCRs were carried out in 35 μl reactions. Each 
amplification reaction included 20 ng of cDNA, 20 pmol 
of each PCR primer and 1 unit of AmpliTaq Gold DNA 
polymerase (Perkin-Elmer, Waltham, MA). These reac-
tions were performed in a buffer 1X containing 1.5 
mmol/L MgCl2, 50 mmol/L KCl, 20 mmol/L Tris-HCl 
(pH 8.4), and 200 pmol/L of each deoxynucleotide tri- 
phosphate. cDNA and control preparations were ampli- 
fied using the following conditions: 95˚C for 2 min fol- 
lowed by 40 cycles of: denaturation for 1 min at 95˚C, 
primer annealing for 1 min at 60˚C, and extension for 1 
min at 72˚C; followed by a final extension at 72˚C for 5 
minutes. Deoxy-oligonucleotide primers were construc- 
ted from the published cDNA sequence of HO-1, Nrf2 
and Cyclophiline A, and the PCR products resulted in 
323, 201 and 166 bp fragments, respectively. Cyclophi- 
line A controls were performed for all PCRs. The pri- 
mers sequences are presented in Table 1. 
The PCR products were electrophoresed on 2% (w/v) 
agarose gel with 0.01% (w/v) ethidium bromide. The 
image was visualized and photographed under UV tran- 
sillumination. The intensity of each band was measured 
using NIH Scion Image 1.6.3 software and reported as 
the values of band intensity units. 
2.7. Statistics 
All results are presented as mean ± SD. Student’s t-test 
was used for the analysis of data with a Gaussian distri- 
bution. The Pearson’s product moment and Spearman’s 
correlation coefficients were used to determine the rela- 
tionships between the studied parameters. Statistical sig- 
nificance was accepted at p < 0.05.  
3. RESULTS 
3.1. Subject Characteristics 
Seventy individuals were included in this study, 40 of 
them were diabetic and 30 were controls. Table 2 shows 
the demographic characteristics of both groups. 54.3% 
were women and 45.7% were men, age distribution was 
not different between the groups with a media age of 
56.3 years old. The average value of BMI was 27.1 
kg/m2 for the control group and 30 kg/m2 for the diabetic 
one. There was a significant difference in weight and 
BMI between both groups. Diabetic female subjects were 
more obese than diabetic male subjects. 
As shown in Table 3, fasting plasma glucose and 
HbA1c concentrations were higher in the diabetic group 
when compared with age-matched control subjects. Total 
cholesterol, TG and LDL-c were increased in the diabetic 
group, while HDL-c was significantly lower in these 
patients, when compared to controls. LDL cholesterol 
was lower in diabetic female than in diabetic male sub-
jects. The atherogenic index (AI) was two fold above the 
control value in the diabetic patients, what suggests a 
higher risk for cardiovascular diseases in these patients. 
Abbreviations used: TG, triglycerides; TC, total cho- 
lesterol; LDL, low density lipoprotein; HDL, high den- 
 
Table 1. Primers sequences for RT-PCR. 
Gen/Gen Bank access Primers Fragment size 
Nfr2 (Homo sapiens NFE2- related factor 2) NM_006164.3 Forward 5’AGATTCACAGGCCTTTCTCG 3’ Reverse 5’ CAGCTCTCCCTACCGTTGAG 3’ 201 bp 
HO-1 (Homo sapiens heme oxigenase 1) NM_002133.2 Forward 5’AGAGCTGCACCGCAAGGCTG’ 3 Reverse 5’ GGGAGTTCATGCGGGAGCGG’ 3 323 bp 
Cyclophiline A (Homo sapiens peptidylprolyl isomerase A) 
NM_021130.3 
Forward 5’ TCCTAAAGCATACGGGTCCTGGCAT 3’ 
Reverse 5’ CGCTCCATGGCCTCCACAATATTCA 3’ 166 bp  
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Table 2. Anthropometric characteristics in control and T2DM 
patients. 
 Control (n = 30) T2DM (n = 40) p 
Gender (F/M) 23/7 15/25  
Age (years) 54.63 ± 10.63 58.13 ± 10.96 0.186
Weight (kg) 73.20 ± 16.08 85.98 ± 18.65 0.004
Height (m) 1.65 ± 0.08 1.67 ± 0.08 0.204
BMI (kg/m2 ) 27.13 ± 5,29 30.00 ± 4.94 0.023
Data are shown as mean ± SD; Abbreviations used: BMI, body mass index. 
 
Table 3. Biochemical characteristics in control and T2DM 
patients. 
 Control (n = 30) DMT2 (n = 40) p 
FPG (mg/dL) 85.10 ± 13.37 149.25 ± 51.74 <0.000 1
HbA1c (%) 5.51 ± 0.74 7.74 ± 2.04 <0.000 1
TC (mg/dL) 172.30 ± 30.28 233.55 ± 38.70 0.001 
HDL-c (mg/dL) 41.60 ± 4.00 34.8 ± 6.30 0.04 
LDL-c (mg/dL) 110.80 ± 26.20 142.1 ± 28.20 0.001 
TG (mg/dl) 127.20 ± 28.16 190.68 ± 56.45 0.001 
AI 3.41 ± 0.65 6.30 ± 1.82 <0.000 1
Data are shown as mean ± SD. 
 
sity lipoprotein; FPG, fasting plasma glucose; HbA1c, 
glycated hemoglobin; AI: TC/HDL-c  
3.2. Prooxidant Status 
The malon-dialdehyde (MDA) concentration was as- 
sessed to evaluate the oxidative stress using the thio- 
barbituric acid-reactive substances (TBAR’S) method. 
The results obtained are consistent, with a significant 
increase in TBAR’S levels in the diabetic group, when 
compared to age-matched control subjects (Figure 1(a)). 
TBAR’S levels were lower in diabetic female than in 
diabetic male subjects (Figure 1(b)). 
3.3. mRNA Expression 
As shown in Figure 2, Nfr2 gene expression was sig- 
nificantly higher (0.90 ± 0.04 Nrf2/Cyclophiline A gene 
expression ratio) in leucocytes from controls when com-
pared to type 2 diabetic patients (0.86 ± 0.04, p < 0.0001). 
Similarly, HO-1 gene expression was significantly higher 
in controls (0.80 ± 0.03 HO-1/Cyclophiline A gene ex- 
pression ratio) when compared to the T2DM patients 
(0.74 ± 0.07, p < 0.003) (Figure 3). Nfr2 and HO-1 gene 







Figure 1. (a) Lipid peroxidation among 
healthy controls and diabetic subjects. 
(b) Lipid peroxidation among female 
and male in diabetic subjects. Data are 






Figure 2. Expression of Nrf2. (a) The bar 
graphs represent the densitometric analy-
sis of Nrf2 gene expression in leucocytes 
of controls (lanes 1 and 2) and type 2 
diabetic patients (lane 3 and 4). (b) The 
expression of Nrf2 was assessed by RT 
PCR, using specific primers, and it was 
normalized against the expression of the 
housekeeping gene Cyclophiline A, as 
reported in Material and Methods. Data 
are expressed as mean ± SEM. 
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Figure 3. Expression of HO-1. (a) The 
bar graphs represent the densitometric 
analysis of HO-1 gene expression in 
leucocytes of controls (lanes 1 and 2) 
and type 2 diabetic patients (lane 3 and 
4). (b) The expression of HO-1 was as-
sessed by RT PCR, using specific prim-
ers, and it was normalized against the 
expression of the housekeeping gene 
Cyclophiline A, as reported in Material 
and Methods. Data are expressed as 
mean ± SEM. 
3.4. Correlation and Lineal Regression  
Studies 
Because both Nrf2 and HO-1 mRNA were reduced in 
the diabetic group, we performed correlations to deter- 
mine whether this reduction was associated with meta- 
bolic factors that are important for insulin resistance. 
When the data from all diabetic patients were pooled 
together, HbA1c was positively correlated with FPG and 
BMI (r = 0.484, p = 0.001; r = 0.307, p = 0.04, respec- 
tively). 
A subsequent linear regression analysis revealed that 
there was a significant and positive correlation between 
the changes of the Nrf2 and HO-1 expression levels, 
independent of the changes of the other measured factors. 
Figure 4 shows the linear regression analysis between 
the expression of Nrf2 and HO-1 in both groups. 
4. DISCUSSION 
Here we measured some anthropometrical, clinical and 
biochemical parameters in a population of men and 
women diagnosed to be T2DM-patients, which reside in 
Juana Koslay city, San Luis—a state located in the cen- 
tral region of Argentina. In this study we report for the 
first time that T2DM patients have lower Nrf2 and HO-1 





Figure 4. (a) Linear regression between 
Nrf2 and HO-1 in the control group. (b) 
Lineal regression between Nrf2 and 
HO-1 in T2DM. 
 
This change was accompanied by an increased plasma 
concentration of TBAR’S.  
Type 2 Diabetes Mellitus (T2DM) is common and is 
characterized by hyperglycemia, insulin resistance, and a 
relative impairment in insulin secretion. Abdominal obe-
sity, specifically, is associated with resistance to the ef-
fects of insulin on the utilization of fatty acids and on 
peripheral glucose levels. Insulin resistance is integral in 
the pathogenesis of T2DM and is frequently accompa-
nied by hypertension, high serum LDL, low serum high- 
density lipoprotein, and high serum triglyceride levels, 
which promote the development of atherosclerotic car-
diovascular disease [20]. 
Hyperglycemia is a major factor in the development of 
diabetic complications, although the mechanisms of how 
increased glucose levels contribute to these changes have 
not been fully elucidated. Adverse biochemical changes 
associated to hyperglycemia include increased flux of 
glucose through the polyol pathway, enhanced nonenzy- 
matic glycation and activation of the diacylglycerol- 
protein kinase C pathway. Hyperglycemia may also re-
sult in increased production of ROS within numerous 
biochemical pathways that have the potential to initiate 
adverse changes in the endothelial function [21]. Oxy-
gen-free radicals had been suggested to be a contributory 
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factor in complications of diabetes mellitus. There are 
many reports that indicate that the changes in biochemi-
cal parameters are due to diabetes-induced oxidative 
stress.  
Our results indicate the presence of higher levels of 
MDA in plasma of type 2 patients as compared to heal- 
thy controls. Increased levels of MDA in diabetic sub-
jects are indication of lipid peroxidation. Increased pro-
duction of MDA has also been demonstrated in the 
erythrocyte membranes of diabetic patients [22,23] and 
high-lipid peroxides levels are also observed in diabetic 
rats [24]. 
Oxidative stress is a consequence of an unbalance be- 
tween the production of oxidants and antioxidants, which 
affects the structure, function and turnover of macro-
molecules leading to tissue dysfunction [25]. Oxidative 
stress has been suggested to be an important mechanism 
in the development of type 2 diabetes [1,2]. Nrf2 main-
tain the balances controlling the antioxidant defense in 
the body which are at stake in a variety of conditions 
including diabetes and diabetic neuropathy. In response 
to oxidative stress, Nrf2 escapes ubiquitination by disso-
ciating from its negative regulator KEAP1 (Kelch-like 
ECH-associated protein 1), translocates to the nucleus, 
and activates the genes involved in the synthesis of anti-
oxidant enzymes [26]. These genes carry a special Nrf2- 
binding site, called the antioxidant response element 
(ARE), in their promoter region [27]. Nrf2 itself contains 
an ARE in its promoter. 
Lipid peroxidation leads to the formation of a number 
of short-length electrophilic fatty acid-derivatives and 
lipid peroxides, which are known to trigger Nrf-2 path- 
way activation and synthesis of antioxidant proteins and 
other proteins involved in the removal of electrophilic 
compounds [28,29]. Although acute activation of Nrf2 
occurs in vivo in response to oxidized phospholipids’ 
signaling, increased ROS production, hyperglycemia, 
and shear stress [30-32], in chronic disease states the 
antioxidant response is often insufficient to maintain re- 
dox balance and prevent disease progression [33,34]. Our 
T2DM patients have increased lipid peroxidation and 
lower Nrf2 mRNA in blood than controls.  
Like many other antioxidant genes, HO-1 gene ex-
pression is triggered by the binding of Nrf2 to the anti-
oxidant response element in its gene’s promoter. In the 
anti-oxidative system, HO-1 acts as a key factor in me- 
chanisms to mitigate oxidative stress because of its po-
tent anti-inflammatory, antioxidant, and anti-proliferative 
actions [12]. In addition, impaired HO-1 protein expres-
sion/activity may be related to the pathogenic process 
induced by oxidative stress. Although accumulating evi-
dence from animal studies supports a beneficial role of 
HO-1 in the diabetic state [12,17], it is still not clear 
whether HO-1 exerts a similar biologic effect in humans. 
We studied HO-1 expression in leucocytes from control 
and T2DM patients. As expected, decreased levels of 
HO-1 mRNA expression were observed in diabetic pa-
tients when compared to healthy controls. These findings 
suggest that reduced HO-1 expression may contribute to 
the development of type 2 diabetes, consistent with the 
results of several small clinical studies which found de-
creased mRNA expression of HO-1 in peripheral blood 
mononuclear cells [35], skeletal muscle [36], and retinal 
pigment epithelium [37] among patients with type 2 dia-
betes. 
Taken together our data indicate that the decreased 
expression of HO-1 and increased levels of TBAR’S 
observed in T2DM could be a consequence of a reduced 
expression of Nrf2. Continuous oxidative stress may be a 
consequence of a reduced capacity of T2DM patients to 
trigger Nrf2-dependent antioxidant response against a 
positive energy balance. 
The results from this study provide novel evidence 
that genes associated to antioxidant defense mechanisms 
are markedly reduced in patients with type 2 diabetes, 
and that the reduction in the expression of these genes 
could be associated to hyperglycemia and increased lev-
els of MDA. The linear regression analysis revealed that 
there is a strong and positive correlation between the 
changes of the Nrf2 and HO-1 expression levels. 
 
REFERENCES 
[1] Baynes, J.W. and Thorpe, S.R. (1999) Role of oxidative 
stress in diabetic complications: A new perspective of an 
old paradigm. Diabetes, 48, 1-9.  
doi:10.2337/diabetes.48.1.1 
[2] Evans, J.L., Goldfine, I.D., Maddux, B.A. and Grodsky, 
G.M. (2002) Oxidative stress and stress-activated signa- 
ling pathways: A unifying hypothesis of type 2 diabetes. 
Endocrine Reviews, 23, 599-622.  
doi:10.1210/er.2001-0039 
[3] Hooper, P.L. (2003) Diabetes, nitric oxide, and heat shock 
proteins. Diabetes Care, 26, 951-952.  
doi:10.2337/diacare.26.3.951 
[4] Rudich, A., Tirosh, A., Potashnik, R., Hemi, R., Kanety, 
H. and Bashan, N. (1998) Prolonged oxidative stress im- 
pairs insulin-induced GLUT4 translocation in 3T3-L1 
adipocytes. Diabetes, 47, 1562-1569.  
doi:10.2337/diabetes.47.10.1562 
[5] King, G.L. and Loeken, M.R. (2004) Hyperglycemia- 
induced oxidative stress in diabetic complications. His-
tochemistry and Cell Biology, 122, 333-338.  
doi:10.1007/s00418-004-0678-9  
[6] Jeong, I.K. and King, G.L. (2011) New perspectives on 
diabetic vascular complications: The loss of endogenous 
protective factors induced by hyperglycemia. Diabetes 
and Metabolism Journal, 35, 8-11.  
doi:10.4093/dmj.2011.35.1.8 
[7] Matough, F.A., Budin, S.B., Hamid, Z.A., Alwahaibi, N. 
Copyright © 2013 SciRes.                                                                    OPEN ACCESS 
S. Siewert et al. / Journal of Diabetes Mellitus 3 (2013) 71-78 77
and Mohamed, J. (2012) The role of oxidative stress and 
antioxidants in diabetic complications. Sultan Qaboos 
University Medical Journal, 12, 5-18. 
[8] Nguyen, T., Nioi, P. and Pickett, C.B. (2009) The Nrf2- 
antioxidant response element signaling pathway and its 
activation by oxidative stress. Journal of Biolpgical Che- 
mistry, 284, 13291-13295. doi:10.1074/jbc.R900010200 
[9] Sykiotis, G.P., Habeos, I.G., Samuelson, A.V. and Boh-
mann, D. (2011) The role of the antioxidant and longev-
ity-promoting Nrf2 pathway in metabolic regulation. Cu- 
rrent Opinion in Clinical Nutrition and Metabolic Care, 
14, 41-48.  
[10] McMahon, M., Itoh, K., Yamamoto, M. and Hayes, J.D. 
(2003) Keap1-dependent proteasomal degradation of 
transcription factor Nrf2 contributes to the negative regu-
lation of antioxidant response element-driven gene ex- 
pression. Journal of Biolpgical Chemistry, 278, 21592- 
21600. doi:10.1074/jbc.M300931200 
[11] Donovan, E.L., McCord, J.M., Reuland, D.J., Miller, B.F. 
and Hamilton, K.L. (2012) Phytochemical activation of 
Nrf2 protects human coronary artery endothelial cells 
against an oxidative challenge. Oxidative Medicine and 
Cellular Longevity, 2012, 9. doi:10.1155/2012/132931 
[12] Deshane, J., Wright, M. and Agarwal, A. (2005) Heme 
oxygenase-1 expression in disease states. Acta Biochi- 
mica Polonica, 52, 273-284. 
[13] Maines, M.D. (1997) The heme oxygenase system: A 
regulator of second messenger gases. Annual Review of 
Pharmacology and Toxicology, 37, 517-554.  
doi:10.1146/annurev.pharmtox.37.1.517 
[14] Otterbein, L.E., Soares, M.P., Yamashita, K. and Bach, 
F.H. (2003) Heme oxygenase-1: Unleashing the pro- tec-
tive properties of heme. Trends in Immunology, 24, 449- 
455. doi:10.1016/S1471-4906(03)00181-9 
[15] Otterbein, L.E. and Choi, A.M. (2000) Heme oxygenase: 
colors of defense against cellular stress. American Jour- 
nal of Physiology, Lung Cellular and Molecular Physiol-
ogy, 279, L1029-L1037. 
[16] Immenschuh, S. and Ramadori, G. (2000) Gene regula-
tion of heme oxygenase-1 as a therapeutic target. Bio-
chemical Pharmacology, 60, 1121-1128.  
doi:10.1016/S0006-2952(00)00443-3 
[17] Song, F., Qi, X., Chen, W., Jia, W., Yao, P., Nussler, A.K., 
Sun, X. and Liu, L. ((2007) Effect of Momordica gros-
venori on oxidative stress pathways in renal mitochondria 
of normal and alloxan-induced diabetic mice. Involve-
ment of heme oxygenase-1. European Journal of Nutri-
tion, 46, 61-69. doi:10.1007/s00394-006-0632-9 
[18] The Expert Committee of the Diagnosis and Classifica-
tion of Diabetes Mellitus. (1997) Report of the expert 
committee on the diagnosis and classification of diabetes 
mellitus. Diabetes Care, 20, 1183-1197. 
[19] Friedewald, W.T., Levy, R.I. and Fredrickson, D.S. (1972) 
Estimation of the concentration of low-density lipopro-
tein cholesterol in plasma, without use of the preparative 
ultracentrifuge. Clinical Chemistry, 18, 499-502. 
[20] DeFronzo, R.A. and Ferrannini, E. (1991) Insulin resis- 
tance. A multifaceted syndrome responsible for NIDDM, 
obesity, hypertension, dyslipidemia, and atherosclerotic 
cardiovascular disease. Diabetes Care, 14, 173-194.  
doi:10.2337/diacare.14.3.173 
[21] Giugliano, D., Ceriello, A. and Paolisso, G. (1996) Oxi- 
dative stress and diabetic vascular complications. Diabe-
tes Care, 19, 257-267. doi:10.2337/diacare.19.3.257 
[22] Mahboob, M., Rahman, M.F. and Grover, P. (2005) Se- 
rum lipid peroxidation and antioxidant enzyme levels in 
male and female diabetic patients. Singapore Medical 
Journal, 46, 322-324. 
[23] Maritim, A.C., Sanders, R.A. and Watkins, J.B. (2003) 
Diabetes, oxidative stress, and antioxidants: A review. 
Journal of Biochemical and Molecular Toxicology, 17, 
24-38. doi:10.1002/jbt.10058 
[24] Unlüçerçi, Y., Bekpinar, S. and Koçak, H. (2000) Testis 
glutathione peroxidase and phospholipid hydroperoxide 
glutathione peroxidase activities in aminoguanidine-trea- 
ted diabetic rats. Archives of Biochemistry and Biophysics, 
379, 217-220. doi:10.1006/abbi.2000.1876 
[25] Ragheb, R., Shanab, G.M., Medhat, A.M., Seoudi, D.M., 
Adeli, K. and Fantus, I.G. (2009) Free fatty acid-induced 
muscle insulin resistance and glucose uptake dysfunction: 
Evidence for PKC activation and oxidative stress acti- 
vated signaling pathways. Biochemical and Biophysical 
Research Communications, 389, 211-216.  
doi:10.1016/j.bbrc.2009.08.106 
[26] Kobayashi, A., Ohta, T. and Yamamoto, M. (2004) Uni- 
que function of the Nrf2-Keap1 pathway in the inducible 
expression of antioxidant and detoxifying enzymes. Me- 
thods in Enzymology, 378, 273-286.  
doi:10.1016/S0076-6879(04)78021-0 
[27] Zhang, D.D. (2006) Mechanistic studies of the Nrf2- 
KEAP1 signaling pathway. Drug Metabolism Reviews, 38, 
769-789. doi:10.1080/03602530600971974 
[28] Motohashi, H. and Yamamoto, M. (2004) Nrf2-Keap1 
defines a physiologically important stress response me- 
chanism. Trends in Molecular Medicine, 10, 549-557.  
doi:10.1016/j.molmed.2004.09.003 
[29] Vomhof-Dekrey, E.E. and Picklo Sr., M.J. (2012) The 
Nrf2-antioxidant response element pathway: A target for 
regulating energy metabolism. Journal of Nutritional Bio- 
chemistry, 23, 1201-1206.  
doi:10.1016/j.jnutbio.2012.03.005 
[30] He, M., Siow, R.C., Sugden, D., Gao, L., Cheng, X. and 
Mann, G.E. (2011) Induction of HO-1 and redox signaling 
in endothelial cells by advanced glycation end products: 
A role for Nrf2 in vascular protection in diabetes. Nutri-
tion, Metabolism and Cardiovascular Diseases, 21, 277- 
285.  
[31] Kadl, A., Meher, A.K., Sharma, P.R., Lee, M.Y., Doran, 
A.C., Johnstone, S.R., Elliott, M.R., Gruber, F., Han, J., 
Chen, W., Kensler, T., Ravichandran, K.S., Isakson, B.E., 
Wamhoff, B.R. and Leitinger, N. (2010) Identification of 
a novel macrophage phenotype that develops in response 
to atherogenic phospholipids via Nrf2. Circulation Re-
search, 107, 737-746.  
doi:10.1161/CIRCRESAHA.109.215715 
[32] Warabi, E., Takabe, W., Minami, T., Inoue, K., Itoh, K., 
Yamamoto, M., Ishii, T., Kodama, T. and Noguchi, N. 
(2007) Shear stress stabilizes NF-E2-related factor 2 and 
induces antioxidant genes in endothelial cells: Role of 
reactive oxygen/nitrogen species. Free Radical Biology 
Copyright © 2013 SciRes.                                                                    OPEN ACCESS 
S. Siewert et al. / Journal of Diabetes Mellitus 3 (2013) 71-78 
Copyright © 2013 SciRes.                                                                    OPEN ACCESS 
78 
and Medicine, 42, 260-269.  
doi:10.1016/j.freeradbiomed.2006.10.043 
[33] Jyrkkänen, H.K., Kansanen, E., Inkala, M., Kivelä, A.M., 
Hurttila, H., Heinonen, S.E., Goldsteins, G., Jauhiainen, 
S., Tiainen, S., Makkonen, H., Oskolkova, O., Afonyu- 
shkin, T., Koistinaho, J., Yamamoto, M., Bochkov. V.N., 
Ylä-Herttuala, S. and Levonen, A.L. (2008) Nrf2 regu-
lates antioxidant gene expression evoked by oxidized 
phospholipids in endothelial cells and murine arteries in 
vivo. Circulation Research, 103, e1-e9.  
doi:10.1161/CIRCRESAHA.108.176883 
[34] Ungvari, Z., Bailey-Downs, L., Gautam, T., Jimenez, R., 
Losonczy, G., Zhang, C., Ballabh P., Recchia, F.A., 
Wilkerson, D.C., Sonntag, W.E., Pearson, K., de Cabo, R. 
and Csiszar, A. (2011) Adaptive induction of 
NF-E2-related factor-2-driven antioxidant genes in endo-
thelial cells in response to hyperglycemia. American 
Journal of Physiology, 300, H1133-H1140.  
doi:10.1152/ajpheart.00402.2010 
[35] Adaikalakoteswari, A., Balasubramanyam, M., Rema, M. 
and Mohan, V. (2006) Differential gene expression of 
NADPH oxidase (p22phox) and hemoxygenase-1 in pa-
tients with type 2 diabetes and microangiopathy. Diabetic 
Medicine, 23, 666-674.  
doi:10.1111/j.1464-5491.2006.01879.x 
[36] Bruce, C.R., Carey, A.L., Hawley, J.A. and Febbraio, 
M.A. (2003) Intramuscular heat shock protein 72 and 
heme oxygenase-1 mRNA are reduced in patients with 
type 2 diabetes: Evidence that insulin resistance is associ-
ated with a disturbed antioxidant defense mechanism. 
Diabetes, 52, 2338-2345. doi:10.2337/diabetes.52.9.2338 
[37] da Silva, J.L., Stoltz, R.A., Dunn, M.W., Abraham, N.G. 
and Shibahara, S. (1997) Diminished heme oxygenase-1 
mRNA expression in RPE cells from diabetic donors as 
quantitated by competitive RT/PCR. Current Eye Re- 
search, 16, 380-386. doi:10.1076/ceyr.16.4.380.10695 
 
 
